Welcome to Dwaey, specifically on Pyrimethamine + Sulfadoxine page.
This medicine contains important and useful components, as it consists of
Pyrimethamine + Sulfadoxine is available in the market in concentration.
Pyrimethamine + Sulfadoxine
Before starting Pyrimethamine + Sulfadoxine combination therapy, it is essential to consult with a healthcare provider to ensure it is appropriate for your condition and health status. Patients should be aware of the following precautions:
- Folate Deficiency: This combination drug can lead to folate deficiency due to the inhibition of dihydrofolate reductase by Pyrimethamine. Patients may require folic acid supplementation to prevent hematologic abnormalities like anemia or leukopenia.
- Bone Marrow Suppression: Both Pyrimethamine and Sulfadoxine can cause bone marrow suppression. Regular blood counts are recommended to monitor for leukopenia, thrombocytopenia, and anemia.
- Liver Function: Since both drugs are metabolized in the liver, patients with liver disease or hepatic impairment should use this combination with caution. Liver function tests should be monitored regularly.
- Renal Function: The combination can affect renal function, and patients with renal impairment should use it cautiously and possibly undergo dosage adjustments. Kidney function must be monitored.
- Pregnancy and Lactation: Pyrimethamine + Sulfadoxine is contraindicated during the first trimester of pregnancy due to potential teratogenic effects. The use during later stages of pregnancy requires careful consultation with a healthcare provider. It is unknown if these drugs pass into breast milk, so caution is advised while breastfeeding.
- G6PD Deficiency: This combination may cause hemolysis in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency. Screening for G6PD deficiency should be considered before use.
Patients should consult their healthcare provider before starting the combination to ensure it is safe and suitable for their health condition.
The combination of Pyrimethamine + Sulfadoxine is primarily used for treating malaria, particularly Plasmodium falciparum infections. The key indications include:
- Treatment of Malaria: This combination is used to treat chloroquine-resistant malaria caused by *Plasmodium falciparum*. The combination works by inhibiting folate metabolism in the malaria parasite, preventing it from synthesizing necessary DNA and RNA, thereby halting parasite growth.
- Prophylaxis of Malaria: Pyrimethamine + Sulfadoxine may also be used in some cases as prophylactic therapy to prevent malaria in travelers to areas with endemic malaria, although this use is less common due to the availability of other treatments.
- Toxoplasmosis: Although not the first-line treatment, this combination can sometimes be used for toxoplasmosis, particularly in immunocompromised individuals, when combined with other drugs like sulfadiazine.
Patients should be prescribed this combination based on a healthcare provider's recommendation, considering the type of malaria or parasitic infection and the patient's medical history.
There are several conditions where Pyrimethamine + Sulfadoxine should not be used:
- Hypersensitivity: Contraindicated in individuals with known hypersensitivity or allergy to sulfonamides, Pyrimethamine, or any of the components in the combination.
- First Trimester of Pregnancy: This combination is contraindicated during the first trimester of pregnancy due to potential teratogenic effects. It should only be used in pregnancy when the benefits outweigh the risks, and after a thorough consultation with a healthcare provider.
- Severe Liver or Renal Disease: In patients with severe liver or kidney dysfunction, the combination should be avoided, as it may exacerbate hepatic or renal toxicity. Dosing adjustments may be needed in mild to moderate cases.
- G6PD Deficiency: In individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency, the combination of Pyrimethamine + Sulfadoxine can lead to hemolytic anemia and should be avoided.
- Children Under 2 Months: The combination should not be used in children under 2 months of age due to the risk of severe side effects like bone marrow suppression and hemolysis.
- Severe Folate Deficiency: In patients with severe folate deficiency, Pyrimethamine + Sulfadoxine should not be used unless adequate folic acid supplementation is given, as it may worsen the deficiency.
The combination of Pyrimethamine + Sulfadoxine may cause both common and severe side effects. Monitoring for side effects is crucial:
Common Side Effects:
- Nausea and vomiting: These are common, especially at the start of treatment.
- Headache: A mild and transient side effect.
- Dizziness: Some patients may experience dizziness, especially when standing up quickly.
Severe Side Effects:
- Bone Marrow Suppression: Both Pyrimethamine and Sulfadoxine can cause bone marrow suppression, which may lead to anemia, leukopenia, or thrombocytopenia. Regular blood tests are essential for monitoring.
- Hematologic Toxicity: Hemolysis can occur, especially in those with G6PD deficiency, leading to severe anemia.
- Liver Toxicity: Both drugs can cause liver enzyme elevations and, in rare cases, hepatitis or liver failure. Liver function tests should be monitored regularly.
- Severe Allergic Reactions: Anaphylaxis or severe rashes can occur, and immediate medical attention is required if symptoms like difficulty breathing, swelling of the face or throat, or fever occur.
- Renal Toxicity: The combination may cause renal impairment or acute kidney failure, especially in those with pre-existing renal conditions.
- Severe Folate Deficiency: Without adequate folic acid supplementation, patients may develop megaloblastic anemia and related complications.
Patients should contact their healthcare provider immediately if they experience persistent fever, unusual bruising or bleeding, sores in the mouth, or yellowing of the skin or eyes, which could indicate severe reactions.
3
The Pyrimethamine + Sulfadoxine combination works synergistically to inhibit folate synthesis in malaria parasites:
- Pyrimethamine inhibits dihydrofolate reductase, an enzyme critical for the conversion of dihydrofolate to tetrahydrofolate, a cofactor essential for the production of nucleic acids (DNA and RNA) in the parasite. This disruption prevents the parasite from replicating.
- Sulfadoxine is a sulfonamide antibiotic that inhibits the dihydropteroate synthase enzyme, which is involved in the synthesis of folic acid in the parasite. By preventing folic acid synthesis, Sulfadoxine further limits the parasite's ability to reproduce.
Together, these two drugs block two critical steps in folate metabolism, effectively killing the malaria parasite.
The Pyrimethamine + Sulfadoxine combination may interact with several medications, which can either reduce its effectiveness or increase the risk of side effects:
- Methotrexate: Both Pyrimethamine and Sulfadoxine can enhance the effects of methotrexate, a folate antagonist, increasing the risk of folate deficiency and hematologic toxicity.
- Anticonvulsants: Phenytoin, carbamazepine, and other anticonvulsants may lower the effectiveness of Pyrimethamine by increasing its metabolism. This may result in suboptimal therapy.
- Warfarin: Pyrimethamine can alter the metabolism of warfarin, increasing the risk of bleeding. Patients taking warfarin should have INR (International Normalized Ratio) monitored regularly.
- Other Antimalarial Drugs: When used with other antimalarial drugs, such as quinine, chloroquine, or artemisinin derivatives, the combination could either cause drug resistance or increase the risk of adverse effects due to cumulative toxicities.
- Sulfonamide Antibiotics: Sulfonamide antibiotics (like trimethoprim-sulfamethoxazole) can enhance the effects of Sulfadoxine and increase the risk of adverse effects, including bone marrow suppression and folate deficiency.
Patients should inform their healthcare provider of any other medications, including over-the-counter drugs, vitamins, or herbal products, to avoid harmful interactions.
For adults, the recommended dose of Pyrimethamine + Sulfadoxine for malaria treatment is:
- Single Dose: Pyrimethamine 25 mg + Sulfadoxine 500 mg as a single dose, which can be repeated if necessary after 24 hours or as prescribed by the healthcare provider.
- For severe malaria, higher doses or alternative therapies may be required, and the treatment should be initiated under medical supervision.
Always follow the prescribed dose and schedule as directed by your healthcare provider.
For children, the dose of Pyrimethamine + Sulfadoxine is based on body weight:
- Children aged 2 months to 5 years: Typically, the dose is Pyrimethamine 12.5 mg + Sulfadoxine 250 mg as a single dose.
- Children aged 6–14 years: Pyrimethamine 25 mg + Sulfadoxine 500 mg is used, usually as a single dose.
The healthcare provider will adjust the dose based on the child's age, weight, and medical condition. Always consult a healthcare provider for the correct dosage.
In patients with renal impairment, the Pyrimethamine + Sulfadoxine combination should be used with caution. Dose adjustments may be necessary, and renal function should be monitored regularly. The dose may need to be reduced, or alternative therapies may be considered in patients with moderate to severe renal disease.
Not available in a medicine form yet